Ispasen Remedies Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 2.00 Cr
- Company Age 2 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.17 Cr
About Ispasen Remedies
Ispasen Remedies Private Limited (IRPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 June 2022 (Two years and seven months 19 days old ). Its registered office is in Banaskantha, Gujarat, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹8.17 Cr.
Ruchi Modh and Urmilaben Modh serve as directors at the Company.
Company Details
-
Location
Banaskantha, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01400GJ2022PTC133143
-
Company No.
133143
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Jun 2022
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Ispasen Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ruchi Modh
|
Director | 22-Jun-2022 | Current |
|
Urmilaben Modh
|
Director | 22-Jun-2022 | Current |
Financial Performance of Ispasen Remedies.
Ispasen Remedies Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ispasen Remedies?
In 2023, Ispasen Remedies had a public holding of 77.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Jyotindra Industries Private LimitedRuchi Modh is a mutual person
-
Shree Swati Agrotech Pvt LtdRuchi Modh is a mutual person
-
Shree Swati Psyllium Private Limited
Ruchi Modh is a mutual person
Charges (Loans)
₹8.17 Cr
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 8.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Oct 2022 | Axis Bank Limited | ₹8.17 Cr | Open |
How Many Employees Work at Ispasen Remedies?
Ispasen Remedies has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ispasen Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ispasen Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.